4.6 Article

Understanding the role of genetic variability in LRRK2 in Indian population

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Geriatrics & Gerontology

Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease

Cornelis Blauwendraat et al.

NEUROBIOLOGY OF AGING (2018)

Article Neurosciences

The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP plus Treatment by Altering LRRK2 Binding to DRP1

Maria Perez Carrion et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)

Article Multidisciplinary Sciences

Structural model of the dimeric Parkinson's protein LRRK2 reveals a compact architecture involving distant interdomain contacts

Giambattista Guaitoli et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Chemistry, Medicinal

Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson's Disease

Paul J. Gilligan

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)

Letter Clinical Neurology

CHCHD2 and Parkinson's disease

Iris E. Jansen et al.

LANCET NEUROLOGY (2015)

Article Geriatrics & Gerontology

NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases

Mike A. Nalls et al.

NEUROBIOLOGY OF AGING (2015)

Article Clinical Neurology

Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers

Dolores Vilas et al.

PARKINSONISM & RELATED DISORDERS (2015)

Article Biochemical Research Methods

SAMBLASTER: fast duplicate marking and structural variant read extraction

Gregory G. Faust et al.

BIOINFORMATICS (2014)

Article Biochemical Research Methods

ABRA: improved coding indel detection via assembly-based realignment

Lisle E. Mose et al.

BIOINFORMATICS (2014)

Article Biotechnology & Applied Microbiology

LRRK2 G2385R and R1628P Mutations Are Associated with an Increased Risk of Parkinson's Disease in the Malaysian Population

Aroma Agape Gopalai et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Review Neurosciences

Movement disorders: Indian scenario: A clinico-genetic review

Shyamal Kumar Das et al.

NEUROLOGY INDIA (2013)

Article Clinical Neurology

Common variation in theLRRK2gene is a risk factor for Parkinson's disease

Ignacio F. Mata et al.

MOVEMENT DISORDERS (2012)

Letter Clinical Neurology

The SNCA (A53T, A30P, E46K) and LRRK2 (G2019S) mutations are rare cause of Parkinson's disease in South Indian patients

M. Vishwanathan Padmaja et al.

PARKINSONISM & RELATED DISORDERS (2012)

Article Neurosciences

LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India

Bejoy Vijayan et al.

NEUROLOGY INDIA (2011)

Article Biochemistry & Molecular Biology

Role of conformational sampling in computing mutation-induced changes in protein structure and stability

Elizabeth H. Kellogg et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)

Review Biochemistry & Molecular Biology

Protein kinases: evolution of dynamic regulatory proteins

Susan S. Taylor et al.

TRENDS IN BIOCHEMICAL SCIENCES (2011)

Article Biochemistry & Molecular Biology

Absence of Commonly Reported Leucine-Rich Repeat Kinase 2 Mutations in Eastern Indian Parkinson's Disease Patients

Jaya Sanyal et al.

GENETIC TESTING AND MOLECULAR BIOMARKERS (2010)

Article Multidisciplinary Sciences

Integrating common and rare genetic variation in diverse human populations

David M. Altshuler et al.

NATURE (2010)

Article Biochemical Research Methods

Fast and accurate short read alignment with Burrows-Wheeler transform

Heng Li et al.

BIOINFORMATICS (2009)

Review Biochemistry & Molecular Biology

LRRK2 in Parkinson's disease: biochemical functions

Vasanti S. Anand et al.

FEBS JOURNAL (2009)

Article Genetics & Heredity

LRRK2 Gene Variation and Its Contribution to Parkinson Disease

Coro Paisan-Ruiz

HUMAN MUTATION (2009)

Article Clinical Neurology

LRRK2 Mutations and Risk Variants in Japanese Patients with Parkinson's Disease

Cyrus P. Zabetian et al.

MOVEMENT DISORDERS (2009)

Article Genetics & Heredity

LRRK2 R1628P increases risk of Parkinson's disease: replication evidence

E. K. Tan et al.

HUMAN GENETICS (2008)

Article Genetics & Heredity

PLINK: A tool set for whole-genome association and population-based linkage analyses

Shaun Purcell et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2007)

Article Biochemistry & Molecular Biology

Apoptotic mechanisms in mutant LRRK2-mediated cell death

Ciro Iaccarino et al.

HUMAN MOLECULAR GENETICS (2007)

Article Biochemistry & Molecular Biology

Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases

K Terasawa et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Article Biochemistry & Molecular Biology

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

A Di Fonzo et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2006)

Article Biochemistry & Molecular Biology

The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity

CJ Gloeckner et al.

HUMAN MOLECULAR GENETICS (2006)

Article Clinical Neurology

Mutational screening of the parkin gene among South Indians with early onset Parkinson's disease

RH Madegowda et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)

Article Clinical Neurology

G2019S LRRK2 mutation in French and North African families with Parkinson's disease

S Lesage et al.

ANNALS OF NEUROLOGY (2005)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY